Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Lancet (London, England)"
topic_facet:"Randomized Controlled Trial"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject&page=9
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject&page=9
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject&page=9
PubPharm (443)
81
Topical imiquimod versus surgery for vulvar intraepithelial neoplasia : a multicentre, randomised, phase 3, non-inferiority trial
enthalten in:
Lancet (London, England)
| 2022
von
Trutnovsky, G.
|
Reich, O.
|
Joura, E.
| +10
CommentIn: Lancet. 2022 May 7;399(10337):1755-1757. - PMID 35483402
Wird geladen...
82
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716) : a randomised, double-blind, phase 3 trial
enthalten in:
Lancet (London, England)
| 2022
von
Luke, J.
|
Rutkowski, P.
|
Queirolo, P.
| +26
CommentIn: Nat Rev Clin Oncol. 2022 Jun;19(6):359. - PMID 35440772
Wird geladen...
83
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1) : a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
enthalten in:
Lancet (London, England)
| 2022
von
Fizazi, K.
|
Foulon, S.
|
Carles, J.
| +31
CommentIn: Lancet. 2022 Apr 30;399(10336):1670-1671. - PMID 35405082
Wird geladen...
84
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children : a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial
enthalten in:
Lancet (London, England)
| 2022
von
Nguyen, T.
|
Chiu, C.
|
Lin, C.
| +18
CommentIn: Lancet. 2022 Apr 30;399(10336):1671-1673. - PMID 35427482
Wird geladen...
85
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L) : a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
enthalten in:
Lancet (London, England)
| 2022
von
Saji, H.
|
Okada, M.
|
Tsuboi, M.
| +18
Wird geladen...
86
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D) : the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
enthalten in:
Lancet (London, England)
| 2022
von
Khobragade, A.
|
Bhate, S.
|
Ramaiah, V.
| +13
CommentIn: Lancet. 2022 Apr 2;399(10332):1281-1282. - PMID 35366995
Wird geladen...
87
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2) : results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
enthalten in:
Lancet (London, England)
| 2022
von
McGarvey, L.
|
Birring, S.
|
Morice, A.
| +12
Wird geladen...
88
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE) : two randomised, double-masked, phase 3, non-inferiority trials
enthalten in:
Lancet (London, England)
| 2022
von
Heier, J.
|
Khanani, A.
|
Quezada Ruiz, C.
| +115
CommentIn: Lancet. 2022 Feb 19;399(10326):697-699. - PMID 35085501
Wird geladen...
89
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE) : two randomised, double-masked, phase 3 trials
enthalten in:
Lancet (London, England)
| 2022
von
Wykoff, C.
|
Abreu, F.
|
Adamis, A.
| +115
Wird geladen...
90
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC) : a double-blind, placebo-controlled, phase 3, randomised trial
enthalten in:
Lancet (London, England)
| 2022
von
ITAC (INSIGHT 013) Study Group
|
Polizzotto, M.
|
Nordwall, J.
| +86
Wird geladen...
[1]
« Vorheriger
4
5
6
7
8
9
10
11
12
13
14
Nächster »
[45]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Lancet (London, England)
Filter aufheben
Thema: Randomized Controlled Trial
Medienart
443
Aufsätze
425
E-Artikel
425
E-Ressourcen
18
Gedruckte Aufsätze
Zeitschriftentitel
Lancet (London, England)
Thema
443
Clinical Trial, Phase III
Randomized Controlled Trial
440
Journal Article
342
Multicenter Study
317
Research Support, Non-U.S. Gov't
117
Comparative Study
74
Antibodies, Monoclonal, Humanized
50
Antibodies, Monoclonal
44
Antineoplastic Agents
27
Klinische Studie
26
Research Support, N.I.H., Extramural
23
EC 2.7.10.1
18
0W860991D6
18
Anti-HIV Agents
18
Clinical Trial, Phase II
18
Deoxycytidine
18
Hypoglycemic Agents
18
Pyrimidines
17
Antirheumatic Agents
17
Cisplatin
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
421
2000-
6
1900-1999
Erscheinungsjahr(e)
Von:
Bis:
Sprache
443
Englisch
Haven't found what you're looking for?
Wird geladen...